Zilurgisertib

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameZilurgisertib
Drug Alias NameINCB-000928INCB-00928
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor type-1 inhibitors
TargetsActivin receptor type-1
Therapy Area/IndicationsOssification, HeterotopicPrimary MyelofibrosisMyelodysplastic Syndromes +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[18] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesIncyte Biosciences (Shanghai) Co LtdMirum PharmaceuticalsIncyte Corp +[4] 
Inactive CompaniesN/A
Active IndicationsOssification, HeterotopicPrimary MyelofibrosisThrombocythemia, Essential +[7] 
Inactive IndicationsMyelodysplastic SyndromesMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A